These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37615330)

  • 1. Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science.
    Rush B; Marcus O; García S; Loizaga-Velder A; Spitalier A; Mendive F
    J Stud Alcohol Drugs; 2024 Sep; 85(5):607-618. PubMed ID: 37615330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center.
    Rush B; Marcus O; García S; Loizaga-Velder A; Loewinger G; Spitalier A; Mendive F
    Front Pharmacol; 2021; 12():659644. PubMed ID: 34093190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study.
    Perkins D; Pagni BA; Sarris J; Barbosa PCR; Chenhall R
    Front Pharmacol; 2022; 13():884703. PubMed ID: 36386199
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada.
    Argento E; Capler R; Thomas G; Lucas P; Tupper KW
    Drug Alcohol Rev; 2019 Nov; 38(7):781-789. PubMed ID: 31489731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who Turns to Amazonian Medicine for Treatment of Substance Use Disorder? Patient Characteristics at the Takiwasi Addiction Treatment Center.
    Berlowitz I; Walt H; Ghasarian C; O'Shaughnessy DM; Mabit J; Rush B; Martin-Soelch C
    J Stud Alcohol Drugs; 2020 Jul; 81(4):416-425. PubMed ID: 32800077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from 'addiction'.
    Talin P; Sanabria E
    Int J Drug Policy; 2017 Jun; 44():23-30. PubMed ID: 28432902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety.
    Giovannetti C; Garcia Arce S; Rush B; Mendive F
    J Psychoactive Drugs; 2020; 52(5):472-481. PubMed ID: 32748709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceremonial Ayahuasca in Amazonian Retreats-Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study.
    Ruffell SGD; Netzband N; Tsang W; Davies M; Butler M; Rucker JJH; Tófoli LF; Dempster EL; Young AH; Morgan CJA
    Front Psychiatry; 2021; 12():687615. PubMed ID: 34177670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study.
    van Oorsouw K; Toennes SW; Ramaekers JG
    Psychopharmacology (Berl); 2022 Jun; 239(6):1839-1852. PubMed ID: 35072760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.
    Palhano-Fontes F; Barreto D; Onias H; Andrade KC; Novaes MM; Pessoa JA; Mota-Rolim SA; Osório FL; Sanches R; Dos Santos RG; Tófoli LF; de Oliveira Silveira G; Yonamine M; Riba J; Santos FR; Silva-Junior AA; Alchieri JC; Galvão-Coelho NL; Lobão-Soares B; Hallak JEC; Arcoverde E; Maia-de-Oliveira JP; Araújo DB
    Psychol Med; 2019 Mar; 49(4):655-663. PubMed ID: 29903051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.
    Perkins D; Schubert V; Simonová H; Tófoli LF; Bouso JC; Horák M; Galvão-Coelho NL; Sarris J
    Front Pharmacol; 2021; 12():623979. PubMed ID: 33967757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being.
    Kiraga MK; Mason NL; Uthaug MV; van Oorsouw KIM; Toennes SW; Ramaekers JG; Kuypers KPC
    Front Pharmacol; 2021; 12():721537. PubMed ID: 34658861
    [No Abstract]   [Full Text] [Related]  

  • 14. Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay.
    Apud I; Scuro J; Carrera I; Oliveri A
    J Psychoactive Drugs; 2023; 55(2):141-150. PubMed ID: 35506737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks.
    Kavenská V; Simonová H
    J Psychoactive Drugs; 2015; 47(5):351-9. PubMed ID: 26514589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey.
    Perkins D; Opaleye ES; Simonova H; Bouso JC; Tófoli LF; GalvÃo-Coelho NL; Schubert V; Sarris J
    Drug Alcohol Rev; 2022 Jan; 41(1):265-274. PubMed ID: 34308566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
    Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study.
    Maia LO; Daldegan-Bueno D; Tófoli LF
    J Psychoactive Drugs; 2021; 53(3):272-282. PubMed ID: 33287690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.